COPD is a highly heterogeneous disease that has a serious impact on affected populations.
Patients share some of the features of bronchial asthma, often summarized under the term ACOS
(asthma-COPD overlap syndrome). The objective of this study is to evaluate the utility of the measurement
of nitric oxide in exhaled air (FENO50) in the diagnosis of COPD phenotypes